FIBROTARGET
@fibrotarget.bsky.social
Horizon Europe project to advance inflammatory bowel disease (#IBD) diagnosis and therapies.
https://fibrotarget.eu/
https://fibrotarget.eu/
Pinned
FIBROTARGET
@fibrotarget.bsky.social
· Dec 17
🎉We're proud to announce that FIBROTARGET
is now in action🎉
This €6M #HorizonEurope project aims to advance inflammatory bowel disease (#IBD) diagnosis and therapies🔬
You can learn more about the 5-year initiative below on our LIVE website🌐
fibrotarget.eu
#fibrosis #fibrostenosis
is now in action🎉
This €6M #HorizonEurope project aims to advance inflammatory bowel disease (#IBD) diagnosis and therapies🔬
You can learn more about the 5-year initiative below on our LIVE website🌐
fibrotarget.eu
#fibrosis #fibrostenosis
📥Stay informed on the latest in IBD fibrosis research
Sign up for the FIBROTARGET newsletter for project updates, research highlights and upcoming events. Clear, accessible insights for researchers, clinicians, patients and the wider community.
Join our growing network!➡️ https://loom.ly/atbot4M
Sign up for the FIBROTARGET newsletter for project updates, research highlights and upcoming events. Clear, accessible insights for researchers, clinicians, patients and the wider community.
Join our growing network!➡️ https://loom.ly/atbot4M
November 25, 2025 at 8:13 AM
📥Stay informed on the latest in IBD fibrosis research
Sign up for the FIBROTARGET newsletter for project updates, research highlights and upcoming events. Clear, accessible insights for researchers, clinicians, patients and the wider community.
Join our growing network!➡️ https://loom.ly/atbot4M
Sign up for the FIBROTARGET newsletter for project updates, research highlights and upcoming events. Clear, accessible insights for researchers, clinicians, patients and the wider community.
Join our growing network!➡️ https://loom.ly/atbot4M
🔍New FIBROTARGET Info Pill!
This edition explains biomarkers - measurable signs that help diagnose, monitor and predict IBD activity.
By studying these indicators, FIBROTARGET aims to improve fibrosis detection and monitoring for better IBD care.
Learn More➡️https://loom.ly/Whlbs78
This edition explains biomarkers - measurable signs that help diagnose, monitor and predict IBD activity.
By studying these indicators, FIBROTARGET aims to improve fibrosis detection and monitoring for better IBD care.
Learn More➡️https://loom.ly/Whlbs78
November 14, 2025 at 10:24 AM
🔍New FIBROTARGET Info Pill!
This edition explains biomarkers - measurable signs that help diagnose, monitor and predict IBD activity.
By studying these indicators, FIBROTARGET aims to improve fibrosis detection and monitoring for better IBD care.
Learn More➡️https://loom.ly/Whlbs78
This edition explains biomarkers - measurable signs that help diagnose, monitor and predict IBD activity.
By studying these indicators, FIBROTARGET aims to improve fibrosis detection and monitoring for better IBD care.
Learn More➡️https://loom.ly/Whlbs78
🚨 Last chance!
Join the IFCCA Academy’s 2nd online module with FIBROTARGET: 🎥 Living with Fibrosis: Challenges, Treatments & Innovations
Learn about the latest in intestinal fibrosis with expert & patient insights.
⏰ Register by 3 Nov: https://lnkd.in/ebXVwYpR
Join the IFCCA Academy’s 2nd online module with FIBROTARGET: 🎥 Living with Fibrosis: Challenges, Treatments & Innovations
Learn about the latest in intestinal fibrosis with expert & patient insights.
⏰ Register by 3 Nov: https://lnkd.in/ebXVwYpR
October 30, 2025 at 8:30 AM
🚨 Last chance!
Join the IFCCA Academy’s 2nd online module with FIBROTARGET: 🎥 Living with Fibrosis: Challenges, Treatments & Innovations
Learn about the latest in intestinal fibrosis with expert & patient insights.
⏰ Register by 3 Nov: https://lnkd.in/ebXVwYpR
Join the IFCCA Academy’s 2nd online module with FIBROTARGET: 🎥 Living with Fibrosis: Challenges, Treatments & Innovations
Learn about the latest in intestinal fibrosis with expert & patient insights.
⏰ Register by 3 Nov: https://lnkd.in/ebXVwYpR
🎤 FIBROTARGET at the 3rd International Workshop on Liver & Gut Fibrosis in Valencia!
Earlier this month, Gianluca Matteoli (KU Leuven) & Elena Ricart (Hospital Clínic de Barcelona) presented, joining experts driving forward fibrosis research.
Learn more about the event ➡️ https://loom.ly/Fci-jmY
Earlier this month, Gianluca Matteoli (KU Leuven) & Elena Ricart (Hospital Clínic de Barcelona) presented, joining experts driving forward fibrosis research.
Learn more about the event ➡️ https://loom.ly/Fci-jmY
October 27, 2025 at 8:01 AM
🎤 FIBROTARGET at the 3rd International Workshop on Liver & Gut Fibrosis in Valencia!
Earlier this month, Gianluca Matteoli (KU Leuven) & Elena Ricart (Hospital Clínic de Barcelona) presented, joining experts driving forward fibrosis research.
Learn more about the event ➡️ https://loom.ly/Fci-jmY
Earlier this month, Gianluca Matteoli (KU Leuven) & Elena Ricart (Hospital Clínic de Barcelona) presented, joining experts driving forward fibrosis research.
Learn more about the event ➡️ https://loom.ly/Fci-jmY
💡FIBROTARGET at #UEGWeek2025!
In Berlin, our session “From bench to bedside in fibrosis innovation” gathered KU Leuven, EFCCA, patient advocates & clinicians to discuss advances in IBD fibrosis and next steps towards clinical trials.
➡️Learn more about FIBROTARGET: https://loom.ly/IGYRLgM
In Berlin, our session “From bench to bedside in fibrosis innovation” gathered KU Leuven, EFCCA, patient advocates & clinicians to discuss advances in IBD fibrosis and next steps towards clinical trials.
➡️Learn more about FIBROTARGET: https://loom.ly/IGYRLgM
October 7, 2025 at 9:34 AM
💡FIBROTARGET at #UEGWeek2025!
In Berlin, our session “From bench to bedside in fibrosis innovation” gathered KU Leuven, EFCCA, patient advocates & clinicians to discuss advances in IBD fibrosis and next steps towards clinical trials.
➡️Learn more about FIBROTARGET: https://loom.ly/IGYRLgM
In Berlin, our session “From bench to bedside in fibrosis innovation” gathered KU Leuven, EFCCA, patient advocates & clinicians to discuss advances in IBD fibrosis and next steps towards clinical trials.
➡️Learn more about FIBROTARGET: https://loom.ly/IGYRLgM
🌟 Join us at #UEGWeek 2025 in Berlin!
FIBROTARGET partners will be there to discuss the latest in fibrosis innovation and patient-centred trial design. Don’t miss the opportunity to connect and explore how we’re advancing research in intestinal fibrosis!
#FIBROTARGET #IBD #FibrosisResearch
FIBROTARGET partners will be there to discuss the latest in fibrosis innovation and patient-centred trial design. Don’t miss the opportunity to connect and explore how we’re advancing research in intestinal fibrosis!
#FIBROTARGET #IBD #FibrosisResearch
September 30, 2025 at 7:30 AM
🌟 Join us at #UEGWeek 2025 in Berlin!
FIBROTARGET partners will be there to discuss the latest in fibrosis innovation and patient-centred trial design. Don’t miss the opportunity to connect and explore how we’re advancing research in intestinal fibrosis!
#FIBROTARGET #IBD #FibrosisResearch
FIBROTARGET partners will be there to discuss the latest in fibrosis innovation and patient-centred trial design. Don’t miss the opportunity to connect and explore how we’re advancing research in intestinal fibrosis!
#FIBROTARGET #IBD #FibrosisResearch
📣We’re pleased to share that FIBROTARGET will be present at UEG Week 2025 in Berlin!
We’ll share progress on advancing research into intestinal fibrosis and fibrostenosis in Crohn’s disease. Stay tuned for details on where to find us!
#UEGWeek #FIBROTARGET #CrohnsDisease #IntestinalFibrosis
We’ll share progress on advancing research into intestinal fibrosis and fibrostenosis in Crohn’s disease. Stay tuned for details on where to find us!
#UEGWeek #FIBROTARGET #CrohnsDisease #IntestinalFibrosis
September 5, 2025 at 7:25 AM
📣We’re pleased to share that FIBROTARGET will be present at UEG Week 2025 in Berlin!
We’ll share progress on advancing research into intestinal fibrosis and fibrostenosis in Crohn’s disease. Stay tuned for details on where to find us!
#UEGWeek #FIBROTARGET #CrohnsDisease #IntestinalFibrosis
We’ll share progress on advancing research into intestinal fibrosis and fibrostenosis in Crohn’s disease. Stay tuned for details on where to find us!
#UEGWeek #FIBROTARGET #CrohnsDisease #IntestinalFibrosis
🔍 Interested in the latest advances in intestinal fibrosis research?
Stay updated with cutting-edge findings, project news & events by signing up for the FIBROTARGET newsletter.
Designed for researchers, clinicians & the wider community.
Join here ➡️ https://loom.ly/atbot4M
Stay updated with cutting-edge findings, project news & events by signing up for the FIBROTARGET newsletter.
Designed for researchers, clinicians & the wider community.
Join here ➡️ https://loom.ly/atbot4M
August 27, 2025 at 7:45 AM
🔍 Interested in the latest advances in intestinal fibrosis research?
Stay updated with cutting-edge findings, project news & events by signing up for the FIBROTARGET newsletter.
Designed for researchers, clinicians & the wider community.
Join here ➡️ https://loom.ly/atbot4M
Stay updated with cutting-edge findings, project news & events by signing up for the FIBROTARGET newsletter.
Designed for researchers, clinicians & the wider community.
Join here ➡️ https://loom.ly/atbot4M
Looking for reliable information on fibrosis?
The FIBROTARGET factsheet is now available in English, Dutch, Spanish, German, French & Italian!
Access key insights on IBD-related fibrosis, created with and for the community in partnership with IFCCA!
Download your copy 👉 https://loom.ly/yW8mEBc
The FIBROTARGET factsheet is now available in English, Dutch, Spanish, German, French & Italian!
Access key insights on IBD-related fibrosis, created with and for the community in partnership with IFCCA!
Download your copy 👉 https://loom.ly/yW8mEBc
August 21, 2025 at 7:30 AM
Looking for reliable information on fibrosis?
The FIBROTARGET factsheet is now available in English, Dutch, Spanish, German, French & Italian!
Access key insights on IBD-related fibrosis, created with and for the community in partnership with IFCCA!
Download your copy 👉 https://loom.ly/yW8mEBc
The FIBROTARGET factsheet is now available in English, Dutch, Spanish, German, French & Italian!
Access key insights on IBD-related fibrosis, created with and for the community in partnership with IFCCA!
Download your copy 👉 https://loom.ly/yW8mEBc
Have you heard the news?🎉
FIBROTARGET coordinator Prof Séverine Vermeire is now the first female rector of KU Leuven in its 600-year history! Prof Gianluca Matteoli takes over as coordinator with Prof Bram Verstockt & FIBROTARGET colleagues across Europe.
More➡️ https://loom.ly/lFmqrcI
FIBROTARGET coordinator Prof Séverine Vermeire is now the first female rector of KU Leuven in its 600-year history! Prof Gianluca Matteoli takes over as coordinator with Prof Bram Verstockt & FIBROTARGET colleagues across Europe.
More➡️ https://loom.ly/lFmqrcI
August 12, 2025 at 7:30 AM
Have you heard the news?🎉
FIBROTARGET coordinator Prof Séverine Vermeire is now the first female rector of KU Leuven in its 600-year history! Prof Gianluca Matteoli takes over as coordinator with Prof Bram Verstockt & FIBROTARGET colleagues across Europe.
More➡️ https://loom.ly/lFmqrcI
FIBROTARGET coordinator Prof Séverine Vermeire is now the first female rector of KU Leuven in its 600-year history! Prof Gianluca Matteoli takes over as coordinator with Prof Bram Verstockt & FIBROTARGET colleagues across Europe.
More➡️ https://loom.ly/lFmqrcI
📚 Looking for scientific publications on intestinal fibrosis and fibrostenosis?
We’ve updated the FIBROTARGET publications page! Now you can easily browse all peer-reviewed research from the project in one place.
🔗 Explore the page➡️: https://loom.ly/oUyA3DU
#IBDresearch #Fibrosis
We’ve updated the FIBROTARGET publications page! Now you can easily browse all peer-reviewed research from the project in one place.
🔗 Explore the page➡️: https://loom.ly/oUyA3DU
#IBDresearch #Fibrosis
August 4, 2025 at 7:30 AM
📚 Looking for scientific publications on intestinal fibrosis and fibrostenosis?
We’ve updated the FIBROTARGET publications page! Now you can easily browse all peer-reviewed research from the project in one place.
🔗 Explore the page➡️: https://loom.ly/oUyA3DU
#IBDresearch #Fibrosis
We’ve updated the FIBROTARGET publications page! Now you can easily browse all peer-reviewed research from the project in one place.
🔗 Explore the page➡️: https://loom.ly/oUyA3DU
#IBDresearch #Fibrosis
🎥 “You are everything else, and you are chronically ill.”
Patient advocate Anastasia Ntanou's story is a powerful reminder: being a patient is just one part of who you are.
💬 Read their full story via FIBROTARGET: loom.ly/QbZj4WU
#PatientVoices #FibrosisAwarenes
Patient advocate Anastasia Ntanou's story is a powerful reminder: being a patient is just one part of who you are.
💬 Read their full story via FIBROTARGET: loom.ly/QbZj4WU
#PatientVoices #FibrosisAwarenes
July 22, 2025 at 10:50 AM
🎥 “You are everything else, and you are chronically ill.”
Patient advocate Anastasia Ntanou's story is a powerful reminder: being a patient is just one part of who you are.
💬 Read their full story via FIBROTARGET: loom.ly/QbZj4WU
#PatientVoices #FibrosisAwarenes
Patient advocate Anastasia Ntanou's story is a powerful reminder: being a patient is just one part of who you are.
💬 Read their full story via FIBROTARGET: loom.ly/QbZj4WU
#PatientVoices #FibrosisAwarenes
📣 New from FIBROTARGET!
Can JAK-STAT signalling help treat IBD fibrosis?
A new review by KU Leuven explores how this immune pathway - already targeted in IBD - might also reduce fibrosis by acting on fibroblasts.
🔗 Read more: loom.ly/AdfSDxo
#IBD #Fibrosis
Can JAK-STAT signalling help treat IBD fibrosis?
A new review by KU Leuven explores how this immune pathway - already targeted in IBD - might also reduce fibrosis by acting on fibroblasts.
🔗 Read more: loom.ly/AdfSDxo
#IBD #Fibrosis
July 14, 2025 at 10:53 AM
📣 New from FIBROTARGET!
Can JAK-STAT signalling help treat IBD fibrosis?
A new review by KU Leuven explores how this immune pathway - already targeted in IBD - might also reduce fibrosis by acting on fibroblasts.
🔗 Read more: loom.ly/AdfSDxo
#IBD #Fibrosis
Can JAK-STAT signalling help treat IBD fibrosis?
A new review by KU Leuven explores how this immune pathway - already targeted in IBD - might also reduce fibrosis by acting on fibroblasts.
🔗 Read more: loom.ly/AdfSDxo
#IBD #Fibrosis
🌍 FIBROTARGET Patient Stories
Meet Anastasia, a patient advocate from Greece living with fibrotic #CrohnsDisease for 15+ years. She shares her story, tackles misconceptions & offers advice for others with the condition.
📖 Read more: loom.ly/QbZj4WU
Meet Anastasia, a patient advocate from Greece living with fibrotic #CrohnsDisease for 15+ years. She shares her story, tackles misconceptions & offers advice for others with the condition.
📖 Read more: loom.ly/QbZj4WU
June 12, 2025 at 8:15 AM
🌍 FIBROTARGET Patient Stories
Meet Anastasia, a patient advocate from Greece living with fibrotic #CrohnsDisease for 15+ years. She shares her story, tackles misconceptions & offers advice for others with the condition.
📖 Read more: loom.ly/QbZj4WU
Meet Anastasia, a patient advocate from Greece living with fibrotic #CrohnsDisease for 15+ years. She shares her story, tackles misconceptions & offers advice for others with the condition.
📖 Read more: loom.ly/QbZj4WU
Today is #WorldIBDDay2025.
We’re proud to stand with EFCCA in saying: #IBDHasNoBorders — Breaking Taboos, Talking About It.
From silent symptoms to fibrotic complications, it’s time to speak up and be heard.
🔗 Discover the campaign: efcca.org/worldibdday2025
We’re proud to stand with EFCCA in saying: #IBDHasNoBorders — Breaking Taboos, Talking About It.
From silent symptoms to fibrotic complications, it’s time to speak up and be heard.
🔗 Discover the campaign: efcca.org/worldibdday2025
May 19, 2025 at 1:34 PM
Today is #WorldIBDDay2025.
We’re proud to stand with EFCCA in saying: #IBDHasNoBorders — Breaking Taboos, Talking About It.
From silent symptoms to fibrotic complications, it’s time to speak up and be heard.
🔗 Discover the campaign: efcca.org/worldibdday2025
We’re proud to stand with EFCCA in saying: #IBDHasNoBorders — Breaking Taboos, Talking About It.
From silent symptoms to fibrotic complications, it’s time to speak up and be heard.
🔗 Discover the campaign: efcca.org/worldibdday2025
Fibrosis in IBD is real — but rarely talked about.
This #WorldIBDDay2025 FIBROTARGET is working to raise awareness and improve prevention, diagnosis and treatment for intestinal fibrosis and fibrostenosis.
🟣 Let’s talk about it.
#IBDHasNoBorders
🔗 fibrotarget.eu/info-pills-i...
This #WorldIBDDay2025 FIBROTARGET is working to raise awareness and improve prevention, diagnosis and treatment for intestinal fibrosis and fibrostenosis.
🟣 Let’s talk about it.
#IBDHasNoBorders
🔗 fibrotarget.eu/info-pills-i...
May 13, 2025 at 3:45 PM
Fibrosis in IBD is real — but rarely talked about.
This #WorldIBDDay2025 FIBROTARGET is working to raise awareness and improve prevention, diagnosis and treatment for intestinal fibrosis and fibrostenosis.
🟣 Let’s talk about it.
#IBDHasNoBorders
🔗 fibrotarget.eu/info-pills-i...
This #WorldIBDDay2025 FIBROTARGET is working to raise awareness and improve prevention, diagnosis and treatment for intestinal fibrosis and fibrostenosis.
🟣 Let’s talk about it.
#IBDHasNoBorders
🔗 fibrotarget.eu/info-pills-i...
💬It’s time to talk.
#IBDHasNoBorders, and neither should our conversations.
FIBROTARGET supports EFCCA's call to break taboos & speak openly about IBD, including hidden complications like fibrosis, on #WorldIBDDay2025!
Let’s start now!
🔗 efcca.org/worldibdday2025
#IBDHasNoBorders, and neither should our conversations.
FIBROTARGET supports EFCCA's call to break taboos & speak openly about IBD, including hidden complications like fibrosis, on #WorldIBDDay2025!
Let’s start now!
🔗 efcca.org/worldibdday2025
April 16, 2025 at 12:15 PM
💬It’s time to talk.
#IBDHasNoBorders, and neither should our conversations.
FIBROTARGET supports EFCCA's call to break taboos & speak openly about IBD, including hidden complications like fibrosis, on #WorldIBDDay2025!
Let’s start now!
🔗 efcca.org/worldibdday2025
#IBDHasNoBorders, and neither should our conversations.
FIBROTARGET supports EFCCA's call to break taboos & speak openly about IBD, including hidden complications like fibrosis, on #WorldIBDDay2025!
Let’s start now!
🔗 efcca.org/worldibdday2025
📣 New FIBROTARGET Publication!
Single-cell technologies could uncover new cell types, biomarkers & pathways associated with fibrosis! These insights could lead to better diagnostics & targeted therapies 💊.
📖 Summary: fibrotarget.eu/ibd-single-c...
🗞️ Full article: gut.bmj.com/content/earl...
Single-cell technologies could uncover new cell types, biomarkers & pathways associated with fibrosis! These insights could lead to better diagnostics & targeted therapies 💊.
📖 Summary: fibrotarget.eu/ibd-single-c...
🗞️ Full article: gut.bmj.com/content/earl...
March 25, 2025 at 1:53 PM
📣 New FIBROTARGET Publication!
Single-cell technologies could uncover new cell types, biomarkers & pathways associated with fibrosis! These insights could lead to better diagnostics & targeted therapies 💊.
📖 Summary: fibrotarget.eu/ibd-single-c...
🗞️ Full article: gut.bmj.com/content/earl...
Single-cell technologies could uncover new cell types, biomarkers & pathways associated with fibrosis! These insights could lead to better diagnostics & targeted therapies 💊.
📖 Summary: fibrotarget.eu/ibd-single-c...
🗞️ Full article: gut.bmj.com/content/earl...
FIBROTARGET GAM#3 wrap-up!
Interested in what we discussed at the FIBROTARGET General Assembly meeting last week in Milan? Discover our key takeaways in our web article!
📰Read our full wrap-up➡️ loom.ly/VDN6Fx4
📹Watch our highlights video below⬇️
Interested in what we discussed at the FIBROTARGET General Assembly meeting last week in Milan? Discover our key takeaways in our web article!
📰Read our full wrap-up➡️ loom.ly/VDN6Fx4
📹Watch our highlights video below⬇️
March 20, 2025 at 8:57 AM
FIBROTARGET GAM#3 wrap-up!
Interested in what we discussed at the FIBROTARGET General Assembly meeting last week in Milan? Discover our key takeaways in our web article!
📰Read our full wrap-up➡️ loom.ly/VDN6Fx4
📹Watch our highlights video below⬇️
Interested in what we discussed at the FIBROTARGET General Assembly meeting last week in Milan? Discover our key takeaways in our web article!
📰Read our full wrap-up➡️ loom.ly/VDN6Fx4
📹Watch our highlights video below⬇️
💫 After two days of insightful discussions, strategic planning, and key project updates, the 3rd FIBROTARGET General Assembly Meeting in Milan is a wrap! 🇮🇹
A huge thank you to everyone who contributed to this productive and inspiring meeting! 🤝🚀
#FIBROTARGET #Collaborativeresearch #HorizonEurope
A huge thank you to everyone who contributed to this productive and inspiring meeting! 🤝🚀
#FIBROTARGET #Collaborativeresearch #HorizonEurope
March 14, 2025 at 5:54 PM
💫 After two days of insightful discussions, strategic planning, and key project updates, the 3rd FIBROTARGET General Assembly Meeting in Milan is a wrap! 🇮🇹
A huge thank you to everyone who contributed to this productive and inspiring meeting! 🤝🚀
#FIBROTARGET #Collaborativeresearch #HorizonEurope
A huge thank you to everyone who contributed to this productive and inspiring meeting! 🤝🚀
#FIBROTARGET #Collaborativeresearch #HorizonEurope
FIBROTARGET GAM: Day 1 at Humanitas University in Milan
Day 1 highlights:
✅ Patient insights from EFCCA
✅ New fibrosis biomarker research 🔬
✅ Cutting-edge imaging 🏥
✅ Laying the groundwork for a clinical trial 🏆
More soon—stay tuned! 🔍
Day 1 highlights:
✅ Patient insights from EFCCA
✅ New fibrosis biomarker research 🔬
✅ Cutting-edge imaging 🏥
✅ Laying the groundwork for a clinical trial 🏆
More soon—stay tuned! 🔍
March 14, 2025 at 9:18 AM
FIBROTARGET GAM: Day 1 at Humanitas University in Milan
Day 1 highlights:
✅ Patient insights from EFCCA
✅ New fibrosis biomarker research 🔬
✅ Cutting-edge imaging 🏥
✅ Laying the groundwork for a clinical trial 🏆
More soon—stay tuned! 🔍
Day 1 highlights:
✅ Patient insights from EFCCA
✅ New fibrosis biomarker research 🔬
✅ Cutting-edge imaging 🏥
✅ Laying the groundwork for a clinical trial 🏆
More soon—stay tuned! 🔍
📣New FIBROTARGET Publication!
Erlangen University Hospital researchers developed an flourescent imaging method to detect fibrosis in #CrohnsDisease!🔬
✅ Identifies #fibrosis & inflammation separately
✅ Could improve #IBD diagnosis & treatment
More➡️ loom.ly/FHiDkTc
Erlangen University Hospital researchers developed an flourescent imaging method to detect fibrosis in #CrohnsDisease!🔬
✅ Identifies #fibrosis & inflammation separately
✅ Could improve #IBD diagnosis & treatment
More➡️ loom.ly/FHiDkTc
February 26, 2025 at 1:50 PM
📣New FIBROTARGET Publication!
Erlangen University Hospital researchers developed an flourescent imaging method to detect fibrosis in #CrohnsDisease!🔬
✅ Identifies #fibrosis & inflammation separately
✅ Could improve #IBD diagnosis & treatment
More➡️ loom.ly/FHiDkTc
Erlangen University Hospital researchers developed an flourescent imaging method to detect fibrosis in #CrohnsDisease!🔬
✅ Identifies #fibrosis & inflammation separately
✅ Could improve #IBD diagnosis & treatment
More➡️ loom.ly/FHiDkTc
🚨Happening NOW!🚨
Join the EFCCA talks webinar on "Living with fibrosis: Challenges, Treatments and Innovations"!
📲Follow the webinar LIVE at the following links:
➡️ Facebook Live: loom.ly/nBBponw
📺 YouTube: loom.ly/6CEjtqw
Looking forward to seeing you there!
Join the EFCCA talks webinar on "Living with fibrosis: Challenges, Treatments and Innovations"!
📲Follow the webinar LIVE at the following links:
➡️ Facebook Live: loom.ly/nBBponw
📺 YouTube: loom.ly/6CEjtqw
Looking forward to seeing you there!
Living with fibrosis: challenges, treatments and innovation.
Other event by EFCCA - European Federation of Crohn's and Ulcerative Colitis Associations on Thursday, February 6 2025
loom.ly
February 6, 2025 at 4:10 PM
🚨Happening NOW!🚨
Join the EFCCA talks webinar on "Living with fibrosis: Challenges, Treatments and Innovations"!
📲Follow the webinar LIVE at the following links:
➡️ Facebook Live: loom.ly/nBBponw
📺 YouTube: loom.ly/6CEjtqw
Looking forward to seeing you there!
Join the EFCCA talks webinar on "Living with fibrosis: Challenges, Treatments and Innovations"!
📲Follow the webinar LIVE at the following links:
➡️ Facebook Live: loom.ly/nBBponw
📺 YouTube: loom.ly/6CEjtqw
Looking forward to seeing you there!
Last call for the EFCCA Talks webinar on Fibrosis!💻
Join us to hear patients and fibrosis experts from the FIBROTARGET project discuss diagnosis, treatment and new therapeutic innovations!🔬
🗓️ 6 Feb 2025 | 🕠 17:30-18:30 CET
💻 Register here➡️ loom.ly/6WdjxOY
Join us to hear patients and fibrosis experts from the FIBROTARGET project discuss diagnosis, treatment and new therapeutic innovations!🔬
🗓️ 6 Feb 2025 | 🕠 17:30-18:30 CET
💻 Register here➡️ loom.ly/6WdjxOY
February 5, 2025 at 9:24 AM
Last call for the EFCCA Talks webinar on Fibrosis!💻
Join us to hear patients and fibrosis experts from the FIBROTARGET project discuss diagnosis, treatment and new therapeutic innovations!🔬
🗓️ 6 Feb 2025 | 🕠 17:30-18:30 CET
💻 Register here➡️ loom.ly/6WdjxOY
Join us to hear patients and fibrosis experts from the FIBROTARGET project discuss diagnosis, treatment and new therapeutic innovations!🔬
🗓️ 6 Feb 2025 | 🕠 17:30-18:30 CET
💻 Register here➡️ loom.ly/6WdjxOY
1️⃣ week to go until the roundtable webinar on Fibrosis with @EFCCA and FIBROTARGET experts! Interested in fibrosis diagnosis, treatment and innovations in fibrosis and research? Register now!
🗓️ 6 Feb 2025
🕠 17:30-18:30 CET
💻 Online
Register here➡️ loom.ly/6WdjxOY
🗓️ 6 Feb 2025
🕠 17:30-18:30 CET
💻 Online
Register here➡️ loom.ly/6WdjxOY
January 31, 2025 at 3:51 PM
1️⃣ week to go until the roundtable webinar on Fibrosis with @EFCCA and FIBROTARGET experts! Interested in fibrosis diagnosis, treatment and innovations in fibrosis and research? Register now!
🗓️ 6 Feb 2025
🕠 17:30-18:30 CET
💻 Online
Register here➡️ loom.ly/6WdjxOY
🗓️ 6 Feb 2025
🕠 17:30-18:30 CET
💻 Online
Register here➡️ loom.ly/6WdjxOY